Part D Plans Undercut Generics In Favor Of Brands Only In 'Limited Instances' – CMS
Executive Summary
CMS will not require Medicare Part D sponsors to cover generic drugs on lowest cost sharing tiers after all, following review of current formulary placement and generic drug access among plans.
You may also be interested in...
Half Of US 'First Generics' Do Not Launch Due To Formulary Obstacles
Medicare Part D program should place generics on tiers separate from brand drugs and create a dedicated tier for specialty generics and biosimilars, AAM advocates in white paper.
Half Of 1st Approved Generics Do Not Launch Due To Part D Formulary Obstacles, AAM Says
Medicare Part D program should place generics on tiers separate from brand drugs and create a dedicated tier for specialty generics and biosimilars, AAM advocates in white paper.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.